Clinical Monitoring Protocol Post-tPA
Following tissue plasminogen activator (tPA) administration for acute ischemic stroke, the patient enters a critical 24-hour monitoring phase. The highest priority is serial neurological assessment to detect intracranial hemorrhage (ICH).
- Perform neurological checks every 15 minutes for the first 2 hours, then every 30 minutes for 6 hours, then hourly until 24 hours post-infusion.
- Assess for: change in level of consciousness, severe headache, nausea/vomiting, acute hypertension, and new focal deficits.
- Maintain strict blood pressure control, typically keeping systolic BP below 180 mmHg and diastolic below 105 mmHg.
- Avoid any anticoagulants or antiplatelet agents (including aspirin) for at least 24 hours.
- Delay placement of nasogastric tubes, urinary catheters, and invasive lines if possible to minimize bleeding risk.
Immediate Actions if ICH is Suspected
If the patient develops signs of intracranial hemorrhage, immediate action is required:
- Stop any remaining tPA infusion immediately.
- Notify the provider and activate the stroke team or rapid response.
- Prepare for emergent non-contrast CT scan of the head.
- Obtain stat labs: PT/PTT, fibrinogen, CBC, and type and crossmatch.
- Anticipate administration of cryoprecipitate or antifibrinolytics as ordered.
Nursing Priority Rationale
The 24-hour post-thrombolysis window carries the highest risk for hemorrhagic transformation. Frequent, structured neurological assessments are the primary means of early detection, allowing for rapid intervention that can be lifesaving. This safety monitoring supersedes other interventions such as early mobilization, medication administration, or rehabilitation consults during this acute phase.